173 related articles for article (PubMed ID: 12859967)
1. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays.
Hsieh HL; Schäfer BW; Sasaki N; Heizmann CW
Biochem Biophys Res Commun; 2003 Jul; 307(2):375-81. PubMed ID: 12859967
[TBL] [Abstract][Full Text] [Related]
2. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
3. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
[TBL] [Abstract][Full Text] [Related]
4. The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine.
Leclerc E; Heizmann CW
Front Biosci (Schol Ed); 2011 Jun; 3(4):1232-62. PubMed ID: 21622268
[TBL] [Abstract][Full Text] [Related]
5. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
6. RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells.
Leclerc E; Heizmann CW; Vetter SW
Gen Physiol Biophys; 2009; 28 Spec No Focus():F65-75. PubMed ID: 20093728
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.
Hoppmann S; Steinbach J; Pietzsch J
Int J Biochem Cell Biol; 2010 May; 42(5):651-61. PubMed ID: 20025991
[TBL] [Abstract][Full Text] [Related]
8. S100 to receptor for advanced glycation end-products binding assay: looking for inhibitors.
Padilla L; Dakhel S; Hernández JL
Biochem Biophys Res Commun; 2014 Mar; 446(1):404-9. PubMed ID: 24613850
[TBL] [Abstract][Full Text] [Related]
9. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
10. Binding of S100 proteins to RAGE: an update.
Leclerc E; Fritz G; Vetter SW; Heizmann CW
Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
[TBL] [Abstract][Full Text] [Related]
11. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
Mohan SK; Gupta AA; Yu C
Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
[TBL] [Abstract][Full Text] [Related]
14. The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.
Meghnani V; Wagh A; Indurthi VS; Koladia M; Vetter SW; Law B; Leclerc E
Int J Biochem Cell Biol; 2014 Dec; 57():54-62. PubMed ID: 25310905
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?
Wolf S; Haase-Kohn C; Lenk J; Hoppmann S; Bergmann R; Steinbach J; Pietzsch J
Amino Acids; 2011 Oct; 41(4):809-20. PubMed ID: 21153848
[TBL] [Abstract][Full Text] [Related]
16. Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.
Cunha C; Giovannini G; Pierini A; Bell AS; Sorci G; Riuzzi F; Donato R; Rodrigues F; Velardi A; Aversa F; Romani L; Carvalho A
PLoS One; 2011; 6(11):e27962. PubMed ID: 22114731
[TBL] [Abstract][Full Text] [Related]
17. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
18. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration.
Nagy N; Brenner C; Markadieu N; Chaboteaux C; Camby I; Schäfer BW; Pochet R; Heizmann CW; Salmon I; Kiss R; Decaestecker C
Lab Invest; 2001 Apr; 81(4):599-612. PubMed ID: 11304580
[TBL] [Abstract][Full Text] [Related]
19. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
20. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages.
Haase-Kohn C; Wolf S; Herwig N; Mosch B; Pietzsch J
Biochem Biophys Res Commun; 2014 Mar; 446(1):143-8. PubMed ID: 24613382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
